"Propylamines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of propylamine (the structural formula NH2CH2CH2CH3).
| Descriptor ID |
D011437
|
| MeSH Number(s) |
D02.092.831
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Propylamines".
Below are MeSH descriptors whose meaning is more specific than "Propylamines".
This graph shows the total number of publications written about "Propylamines" by people in this website by year, and whether "Propylamines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 5 | 0 | 5 |
| 2014 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Propylamines" by people in Profiles.
-
Hyperpolarized Porous Silicon Nanoparticles: Potential Theragnostic Material for 29 Si Magnetic Resonance Imaging. Chemphyschem. 2018 09 05; 19(17):2143-2147.
-
Contact lens care solution killing efficacy against Acanthamoeba castellanii by in vitro testing and live-imaging. Cont Lens Anterior Eye. 2015 Dec; 38(6):442-50.
-
(99m)Tc-labeled aminosilane-coated iron oxide nanoparticles for molecular imaging of a??3-mediated tumor expression and feasibility for hyperthermia treatment. J Colloid Interface Sci. 2014 Nov 01; 433:163-175.
-
Pharmacologic mood destabilization: case vignettes. CNS Spectr. 2009 Nov; 14(11 Suppl 11):9-11; discussion 12-4.
-
Atomoxetine for freezing of gait in Parkinson disease. J Neurol Sci. 2009 Sep 15; 284(1-2):177-8.
-
Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: a pilot open-label study. Mov Disord. 2009 Jan 30; 24(2):277-82.
-
Atomoxetine attenuates dextroamphetamine effects in humans. Am J Drug Alcohol Abuse. 2009; 35(6):412-6.
-
Successful medication withdrawal after cognitive-behavioral therapy in a treatment-resistant preadolescent male with obsessive-compulsive disorder. Depress Anxiety. 2009; 26(1):E23-5.
-
Pharmacotherapy with atomoxetine for US children and adolescents. Ann Clin Psychiatry. 2007 Jul-Sep; 19(3):175-80.
-
Dopamine transporter genotype influences the physiological response to medication in ADHD. Brain. 2006 Aug; 129(Pt 8):2038-46.